780 related articles for article (PubMed ID: 26177090)
1. Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.
Locke JE; Durand C; Reed RD; MacLennan PA; Mehta S; Massie A; Nellore A; DuBay D; Segev DL
Transplantation; 2016 Jan; 100(1):141-6. PubMed ID: 26177090
[TBL] [Abstract][Full Text] [Related]
2. Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States.
Sawinski D; Goldberg DS; Blumberg E; Abt PL; Bloom RD; Forde KA
Clin Infect Dis; 2015 Oct; 61(7):1054-62. PubMed ID: 26082506
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
[TBL] [Abstract][Full Text] [Related]
4. Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States.
Campos-Varela I; Dodge JL; Berenguer M; Adam R; Samuel D; Di Benedetto F; Karam V; Belli LS; Duvoux C; Terrault NA
Transplantation; 2020 Oct; 104(10):2078-2086. PubMed ID: 32969987
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection.
Terrault NA; Roland ME; Schiano T; Dove L; Wong MT; Poordad F; Ragni MV; Barin B; Simon D; Olthoff KM; Johnson L; Stosor V; Jayaweera D; Fung J; Sherman KE; Subramanian A; Millis JM; Slakey D; Berg CL; Carlson L; Ferrell L; Stablein DM; Odim J; Fox L; Stock PG;
Liver Transpl; 2012 Jun; 18(6):716-26. PubMed ID: 22328294
[TBL] [Abstract][Full Text] [Related]
6. A National Study of Outcomes among HIV-Infected Kidney Transplant Recipients.
Locke JE; Mehta S; Reed RD; MacLennan P; Massie A; Nellore A; Durand C; Segev DL
J Am Soc Nephrol; 2015 Sep; 26(9):2222-9. PubMed ID: 25791727
[TBL] [Abstract][Full Text] [Related]
7. The corrected donor age for hepatitis C virus-infected liver transplant recipients.
Dirchwolf M; Dodge JL; Gralla J; Bambha KM; Nydam T; Hung KW; Rosen HR; Feng S; Terrault NA; Biggins SW
Liver Transpl; 2015 Aug; 21(8):1022-30. PubMed ID: 26074140
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing hepatitis C virus and improved outcomes in overall and kidney graft survival among simultaneous liver-kidney transplant recipients in the post-MELD era.
Latt NL; Alachkar N; Taydas E; Cameron A; Gurakar A
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():45-9. PubMed ID: 24635792
[TBL] [Abstract][Full Text] [Related]
9. Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Liver Transpl; 2019 Apr; 25(4):598-609. PubMed ID: 30716208
[TBL] [Abstract][Full Text] [Related]
10. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
Watt KD; Dierkhising R; Heimbach JK; Charlton MR
Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
[TBL] [Abstract][Full Text] [Related]
11. Low, rather than high, body mass index confers increased risk for post-liver transplant death and graft loss: Risk modulated by model for end-stage liver disease.
Bambha KM; Dodge JL; Gralla J; Sprague D; Biggins SW
Liver Transpl; 2015 Oct; 21(10):1286-94. PubMed ID: 26097202
[TBL] [Abstract][Full Text] [Related]
12. Pros and cons of liver transplantation in human immunodeficiency virus infected recipients.
Baccarani U; Righi E; Adani GL; Lorenzin D; Pasqualucci A; Bassetti M; Risaliti A
World J Gastroenterol; 2014 May; 20(18):5353-62. PubMed ID: 24833865
[TBL] [Abstract][Full Text] [Related]
13. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
14. Liver transplant recipients and prioritization of anti-HCV therapy: an Italian cohort analysis.
Lanini S; Nanni Costa A; Grossi PA; Procaccio F; Ricci A; Capobianchi MR; Terrault NA; Ippolito G
Liver Int; 2016 Mar; 36(3):410-7. PubMed ID: 26264452
[TBL] [Abstract][Full Text] [Related]
15. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
[TBL] [Abstract][Full Text] [Related]
16. Early Predictors of Long-term Outcomes of HCV-negative Liver Transplant Recipients Having Survived the First Postoperative Year.
Åberg F; Nordin A; Toivonen L; Isoniemi H
Transplantation; 2016 Feb; 100(2):382-90. PubMed ID: 26683515
[TBL] [Abstract][Full Text] [Related]
17. Outcome of liver transplantation for recipients with hepatitis B and hepatitis C virus coinfection: analysis of the UNOS data.
Waki K; Sugawara Y; Tamura S; Mieno MN; Yamashiki N; Kadowaki T; Kokudo N
Transplantation; 2011 Oct; 92(7):809-14. PubMed ID: 21832961
[TBL] [Abstract][Full Text] [Related]
18. Chronic kidney disease after liver transplantation in human immunodeficiency virus/hepatitis C virus-coinfected recipients versus human immunodeficiency virus-infected recipients without hepatitis C virus: results from the National Institutes of Health multi-site study.
Bahirwani R; Barin B; Olthoff K; Stock P; Murphy B; Rajender Reddy K;
Liver Transpl; 2013 Jun; 19(6):619-26. PubMed ID: 23512786
[TBL] [Abstract][Full Text] [Related]
19. Improved Survival After Liver Transplantation for Patients With Human Immunodeficiency Virus (HIV) and HIV/Hepatitis C Virus Coinfection in the Integrase Strand Transfer Inhibitor and Direct-Acting Antiviral Eras.
Jacob JS; Shaikh A; Goli K; Rich NE; Benhammou JN; Ahmed A; Kim D; Rana A; Goss JA; Naggie S; Lee TH; Kanwal F; Cholankeril G
Clin Infect Dis; 2023 Feb; 76(4):592-599. PubMed ID: 36221143
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.
Gitto S; Belli LS; Vukotic R; Lorenzini S; Airoldi A; Cicero AF; Vangeli M; Brodosi L; Panno AM; Di Donato R; Cescon M; Grazi GL; De Carlis L; Pinna AD; Bernardi M; Andreone P
World J Gastroenterol; 2015 Apr; 21(13):3912-20. PubMed ID: 25852276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
